|
|
Blood, 1 February 2004, Vol. 103, No. 3, pp. 903-911.
Prepublished online as a Blood First Edition Paper on September 22, 2003; DOI 10.1182/blood-2003-01-0308.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody
Peter A. Smethurst,
Lotta Joutsi-Korhonen,
Marie N. O'Connor,
Erica Wilson,
Nicola S. Jennings,
Stephen F. Garner,
Yanjun Zhang,
C. Graham Knight,
Timothy R. Dafforn,
Ashley Buckle,
Martin J. W. IJsseldijk,
Philip G. de Groot,
Nicholas A. Watkins,
Richard W. Farndale, and
Willem H. Ouwehand
From the Department of Haematology, University of Cambridge, United Kingdom; National Blood Service, Cambridge, United Kingdom; Department of Biochemistry, University of Cambridge, United Kingdom; Centre for Protein Engineering, Medical Research Council, Cambridge, United Kingdom; and Department of Haematology, University Medical Center, Utrecht, The Netherlands.
Glycoprotein (GP) VI is the major receptor responsible for platelet activation by collagen, but the collagen-binding surface of GPVI is unknown. To address this issue we expressed, from insect cells, the immunoglobulin (Ig)like ectodomains (residues 1-185) of human and murine GPVI, called hD1D2 and mD1D2, respectively. Both proteins bound specifically to collagen-related peptide (CRP), a GPVI-specific ligand, but hD1D2 bound CRP more strongly than did mD1D2. Molecular modeling and sequence comparison identified key differences between hD1D2 and mD1D2. Ten mutant hD1D2s were expressed, of which 4 had human residues replaced by their murine counterpart, and 6 had replacements by alanine. CRP binding studies with these mutants demonstrated that the exchange of lysine at position 59 for the corresponding murine glutamate substantially reduced binding to CRP. The position of lysine59 on the apical surface of GPVI suggests a mode of CRP binding analogous to that used by the related killer cell Ig-like receptors to bind HLA. This surface was confirmed as critical for collagen binding by epitope mapping of an inhibitory phage antibody against GPVI. This anti-GPVI, clone 10B12, gave dose-dependent inhibition of the hD1D2-collagen interaction. Clone 10B12 inhibited activation of platelets by CRP and collagen in aggregometry and thrombus formation by the latter in whole blood perfusion. Antibody 10B12 showed significantly reduced binding to the hD1D2-E59, and, on that basis, the GPVI:10B12 interface was modeled.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Dumont, D. Lasne, C. Rothschild, M. Bouabdelli, V. Ollivier, C. Oudin, N. Ajzenberg, B. Grandchamp, and M. Jandrot-Perrus
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations
Blood,
August 27, 2009;
114(9):
1900 - 1903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Herr and R. W. Farndale
Structural Insights into the Interactions between Platelet Receptors and Fibrillar Collagen
J. Biol. Chem.,
July 24, 2009;
284(30):
19781 - 19785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kato-Takagaki, Y. Mizukoshi, Y. Yoshizawa, D. Akazawa, Y. Torii, K. Ono, R. Tanimura, I. Shimada, and H. Takahashi
Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library
J. Biol. Chem.,
April 17, 2009;
284(16):
10720 - 10727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Jarvis, N. Raynal, J. P. Langford, D. J. Onley, A. Andrews, P. A. Smethurst, and R. W. Farndale
Identification of a major GpVI-binding locus in human type III collagen
Blood,
May 15, 2008;
111(10):
4986 - 4996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, S. Lockyer, A. Concepcion, X. Gong, H. Takizawa, M. Guertin, Y. Matsumoto, J. Kambayashi, N. N. Tandon, and Y. Liu
The Fab Fragment of a Novel Anti-GPVI Monoclonal Antibody, OM4, Reduces In Vivo Thrombosis Without Bleeding Risk in Rats
Arterioscler Thromb Vasc Biol,
May 1, 2007;
27(5):
1199 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Smethurst, D. J. Onley, G. E. Jarvis, M. N. O'Connor, C. G. Knight, A. B. Herr, W. H. Ouwehand, and R. W. Farndale
Structural Basis for the Platelet-Collagen Interaction: THE SMALLEST MOTIF WITHIN COLLAGEN THAT RECOGNIZES AND ACTIVATES PLATELET GLYCOPROTEIN VI CONTAINS TWO GLYCINE-PROLINE-HYDROXYPROLINE TRIPLETS
J. Biol. Chem.,
January 12, 2007;
282(2):
1296 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. O'Connor, P. A. Smethurst, L. W. Davies, L. Joutsi-Korhonen, D. J. Onley, A. B. Herr, R. W. Farndale, and W. H. Ouwehand
Selective Blockade of Glycoprotein VI Clustering on Collagen Helices
J. Biol. Chem.,
November 3, 2006;
281(44):
33505 - 33510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zahn, N. Jennings, W. H. Ouwehand, and J.-P. Allain
Hepatitis C virus interacts with human platelet glycoprotein VI.
J. Gen. Virol.,
August 1, 2006;
87(Pt 8):
2243 - 2251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Horii, M. L. Kahn, and A. B. Herr
Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI
Blood,
August 1, 2006;
108(3):
936 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Raynal, S. W. Hamaia, P. R.-M. Siljander, B. Maddox, A. R. Peachey, R. Fernandez, L. J. Foley, D. A. Slatter, G. E. Jarvis, and R. W. Farndale
Use of Synthetic Peptides to Locate Novel Integrin {alpha}2beta1-binding Motifs in Human Collagen III
J. Biol. Chem.,
February 17, 2006;
281(7):
3821 - 3831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takayama, Y. Hosaka, K. Nakayama, K. Shirakawa, T. Kawahara, K. Naitoh, M. Shinozaki, M. Honda, T. Yamakawa, and S. Furusako
Characterization of Anti-Human GPVI Autoantibodies Mediating Persistent Target Immnunodepletion over a 15-Year Period.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
2168 - 2168.
[Abstract]
|
 |
|

|
 |

|
 |
 
S. Penz, A. J. Reininger, R. Brandl, P. Goyal, T. Rabie, I. Bernlochner, E. Rother, C. Goetz, B. Engelmann, P. A. Smethurst, et al.
Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI
FASEB J,
June 1, 2005;
19(8):
898 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R.-M. Siljander, S. Hamaia, A. R. Peachey, D. A. Slatter, P. A. Smethurst, W. H. Ouwehand, C. G. Knight, and R. W. Farndale
Integrin Activation State Determines Selectivity for Novel Recognition Sites in Fibrillar Collagens
J. Biol. Chem.,
November 12, 2004;
279(46):
47763 - 47772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Gibbins
Platelet adhesion signalling and the regulation of thrombus formation
J. Cell Sci.,
July 15, 2004;
117(16):
3415 - 3425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Barrow, E. Astoul, A. Floto, G. Brooke, I. A. M. Relou, N. S. Jennings, K. G. C. Smith, W. Ouwehand, R. W. Farndale, D. R. Alexander, et al.
Cutting Edge: TREM-Like Transcript-1, a Platelet Immunoreceptor Tyrosine-Based Inhibition Motif Encoding Costimulatory Immunoreceptor that Enhances, Rather than Inhibits, Calcium Signaling via SHP-2
J. Immunol.,
May 15, 2004;
172(10):
5838 - 5842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Kahn
Platelet collagen receptors play molecular ping-pong
Blood,
February 15, 2004;
103(4):
1180 - 1181.
[Full Text]
[PDF]
|
 |
|
|
|